-
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
26 Apr 2025 21:50 GMT
… Phase 2b HERIZON-BTC-01 trial, which evaluated zanidatamab in previously … Zealand].
The FDA granted Breakthrough Therapy designation for zanidatamab development in patients … disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient …
-
How autism could be beaten with a 10p vitamin pill. A top doctor tells ETHAN ENNALS his breakthrough... and how just two weeks after treatment non-verbal Ryan said 'I love you Dad' for first time
26 Apr 2025 16:03 GMT
… autism skyrocketing?
The lifelong developmental disorder – which begins in … improvements within weeks of starting treatment.
Significantly, he also … 20 years ago.’
The epilepsy drug sodium valproate has … just joined a medical trial, it might appear this …
-
GENERATION HD2 Trial Amended, NeuroOne Completes Submission for OneRF Ablation System, FDA Authorizes Implantable Continuous EEG Monitoring System
26 Apr 2025 11:03 GMT
… phase 3 GENERATION HD2 trial (NCT05686551) to include … FDA submission for its proprietary OneRF Ablation System for the treatment … States for patients with epilepsy. The device is expected … open-design, case-controlled trial conducted in Australian hospitals …
-
Symphony Robotics Welcomes Neurosurgery Leader Dr. Neil A. Martin As Chief Medical Officer To Revolutionize Glioblastoma Treatment With First-Ever MRI-Steerable Micro-Robotics
25 Apr 2025 23:41 GMT
… ;Glioblastoma remains the most treatment-resistant and lethal primary … translational research pipeline for developing applications to accompany and … GBM and medically refractory epilepsy, the company aims to … Food and Drug Administration (FDA) and are not …
-
Researchers Develop Phospholipid Composition That Optimizes CBD Absorption
25 Apr 2025 20:37 GMT
… Australia researchers have developed an innovative solution to … with multiple sclerosis, epilepsy, and other neurodegenerative disorders … side effects and making treatment more cost-effective.” … of other water-soluble medications. The team plans …
-
Epilepsy after brain injury increases risk of premature death
24 Apr 2025 17:00 GMT
… similar brain injury without developing epilepsy. This has been shown … , of which 4,292 developed epilepsy after their brain injury. … higher in people who developed epilepsy after a brain injury … made in time and appropriate treatment can begin," Markus …
-
Epiminder receives US FDA authorisation for Minder, its proprietary implantable continuous electroencephalogram monitoring system for patients with epilepsy
24 Apr 2025 11:11 GMT
… Breakthrough Technology by the FDA, recognising its potential … able to rapidly adjust medication or neuromodulation regimens and … , case-controlled comparator trial that was undertaken in … focused on developing diagnostic and treatment tools for epilepsy and …
-
Epiminder’s implantable EEG system for epilepsy receives FDA authorisation
23 Apr 2025 20:09 GMT
… Food and Drug Administration (FDA) authorisation through the … design, prospective, case-controlled trial, UMPIRE, which was conducted … the comprehension and treatment of underlying health issues … and exploring other treatment options.
Epilepsy is said to …
-
FDA grants Breakthrough approval for Epiminder’s Implantable EEG System for epilepsy monitoring
23 Apr 2025 17:46 GMT
… FDA application was supported by data from the UMPIRE clinical trial … officer, said the trial “exceeded our expectations,” … of drug-resistant epilepsy.
With FDA approval secured, … epilepsy treatment. New anti-seizure medications continue to be developed …
-
FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment
23 Apr 2025 19:02 GMT
… -design, case-controlled trial conducted in Australian hospitals … : adjustments to antiseizure medications (ASMs), implementation of … s eligibility for surgical treatment.
Importantly, clinicians … drug resistant epilepsy."
REFERENCES
1. FDA Grants …
About
© 1995-2025